APPILI THERAPEUTICS INC-CL A (APLI.CA)
CA03783R1073 - Common Stock
| TTM (2024-9-30) | 2024 (2024-3-31) | 2023 (2023-3-31) | 2022 (2022-3-31) | 2021 (2021-3-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -3.58M | -3.78M | -9.24M | -25.12M | -14.33M | |||
| Depreciation Amortization | 9.84K | 13.66K | 10.00K | 10.00K | 10.00K | |||
| Change In Working Capital | 1.57M | 661.44K | -3.24M | 2.49M | 1.64M | |||
| Interest Paid | 1.72M | 1.10M | 80.00K | 90.00K | 20.00K | |||
| Taxes Paid | N/A | 62.60K | N/A | N/A | N/A | |||
| Other non cash items | 2.07M | 641.38K | 2.37M | 3.54M | 1.22M | |||
| OPERATING CASH FLOW | 72.52K | -2.46M | -10.10M | -19.08M | -11.45M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | N/A | -29.72K | 0.00 | 0.00 | -10.00K | |||
| Other Investing Activity | N/A | 650.00 | 0.00 | 5.06M | -4.98M | |||
| INVESTING CASH FLOW | -720.00 | -29.06K | 0.00 | 5.06M | -4.99M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | 274.18K | 203.58K | 2.41M | 3.83M | -20.00K | |||
| Stock Issued/Repurchased | N/A | 0.00 | 4.50M | 7.04M | 18.46M | |||
| Other Financing Activity | -76.67K | -81.53K | -1.01M | -1.31M | -1.42M | |||
| FINANCING CASH FLOW | 197.50K | 122.05K | 5.91M | 9.56M | 17.02M | |||
| Exchange Rate Effect | 30.00 | 50.00 | -10.00K | 60.00K | -20.00K | |||
| CHANGE IN CASH | 269.33K | -2.37M | -4.20M | -4.40M | 560.00K | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | 72.52K | -2.46M | -10.10M | -19.08M | -11.45M | |||
| Capital Expenditure | N/A | -29.72K | 0.00 | 0.00 | -10.00K | |||
| FREE CASH FLOW | 71.14K | -2.49M | -10.10M | -19.08M | -11.46M | |||
All data in CAD